Stock KANEH BOSM BIOTECHNOLOGY INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Kaneh Bosm Biotechnology Inc Canadian Securities Exchange

Equities

CA4841902022

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
TRANSNATIONAL CANNABIS LTD Announces Director Changes
CI
TRANSNATIONAL CANNABIS LTD Announces Resignation of Brendan Purdy as Interim-CFO
CI
ICC International Cannabis Corp. (CNSX:WRLD.U) cancelled the acquisition of Grupo Pharma Colombiano Inc. for CAD 4.3 million.
CI
ICC International Cannabis Corp. (CNSX:WRLD.U) cancelled the letter of intent to acquire Farma Swiss S.A.S. from AgraFlora Organics International Inc
CI
TRANSNATIONAL CANNABIS LTD (OTCPK:WLDC.F) entered into a definitive agreement to acquire Trichome International Brands Inc. for CAD 0.24 million.
CI
ICC International Cannabis Corp. has Changed its Name to Transnational Cannabis Ltd
CI
Icc International Cannabis Corp. Reports Earnings Results for the Third Quarter Ended November 30, 2019
CI
ICC International Cannabis Corp. Announces the Appointment of Brendan Purdy as Interim CFO
CI
Sixth Wave Innovations Inc. announced that it has received CAD 10.673684 million in funding from ICC International Cannabis Corp.
CI
Ebersbach Facility, Haxxon, Theros Pharma, Gardina Pharmaceutical, 819 Ha Agri Land & Tropicann cancelled the acquisition of ICC International Cannabis Corp. (CNSX:WRLD.U) in a reverse merger transaction.
CI
ICC International Cannabis Corp. Announces the Resignation of Peter Nguyen as Director and CFO
CI
ICC International Cannabis Corp. (CNSX:WRLD.U) cancelled the acquisition of 49.9% stake in Maricann B.V. from Wayland Group Corp..
CI
Icc International Cannabis Corp. Reports Earnings Results for the Second Quarter Ended August 31, 2019
CI
ICC International Cannabis Corp. announced that it has received CAD 2.5 million in funding
CI
Icc International Cannabis Corp. Reports Earnings Results for the First Quarter Ended May 31, 2019
CI
ICC International Cannabis Corp. to Supply New Zealand’s NUBU Pharmaceuticals with Portfolio of Full-Spectrum Pharmaceutical THC/CBD Products
CI
Kaneh Bosm BioTechnology Inc. cancelled the acquisition of Farmakem Ltd.
CI
Icc International Cannabis Corp. Reports Earnings Results for the Full Year Ended February 28, 2019
CI
ICC International Cannabis Corp. Auditor Raises 'Going Concern' Doubt
CI
International Cannabis Completes Technical Feasibility Study for Danish Gacp/Eu-Gmp Certified Greenfield Cultivation and Processing Facility
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TRCNF Stock
  4. Stock
  5. News Kaneh Bosm Biotechnology Inc